Company news

Camurus AB news in 2025

Camurus AB's news releases, calls and decks from 2025, newest first.

View company

Camurus reports positive topline results for CAM2056, semaglutide monthly depot

November 10, 2025

Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK

August 28, 2025

Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU

July 1, 2025

Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

June 18, 2025

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

June 3, 2025

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

April 25, 2025

Calls in 2025

Decks in 2025